Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
Fundación Pública Andaluza para la investigación Biosanitaria de Andalucía oriental (FIBAO)
Melatonin analogous for cancer treatment
A research group from the Andalusian Public Health Service (SSPA) has developed a melatonin analogous (Agomelatine) to treat cancer.
Melatonin affects cell proliferation in a variety of tumor cell lines, both in physiological and pharmacological concentrations.
This research group has demonstrated that a melatonin analogue, called agomelatine, inhibits the growth of cell lines of colon cancer in vitro and in vivo, suggesting the oncostatic / cytotoxic role of this compound.
Related links:
Tags: cancerfibaoterapydrugmelatonin